| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ef3da5e5f4924f28cd488b6804024c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9699630143f59118bb4eaa55fcc2b525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ae42e3d760f601a4065282ba163db02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a933a0dd561e3e50b278738704d5c6e6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-10 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6875
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate |
2004-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a369a5cb8d9c5bd60327f1f2d617a9f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e41ab49eb1a480ce2fa6addf52f9f989
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_204b100e94fef07ad06f8616f3b846b4 |
| publicationDate |
2004-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004064770-A2 |
| titleOfInvention |
Use of smad3 inhibitor in the treatment of fibrosis dependent on epithelial to mesenchymal transition as in the eye and kidney |
| abstract |
The invention is related to inhibition of Smad3 to ameliorate Smad3 mediated epithelial to mesenchymal transition. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018150188-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10195249-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008046964-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2026773-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008046964-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10550170-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11524990-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017091706-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2026773-A4 |
| priorityDate |
2003-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |